CAJ | 학술논문

甲状腺髓样癌是一种少见的甲状腺恶性肿瘤，由于其起源于甲状腺滤泡旁 C 细胞，故与针对其他常见的甲状腺肿瘤如甲状腺乳头状癌等的治疗方法有所不同，具有自身的特点。近年来，使用酪氨酸激酶抑制剂的靶向治疗为甲状腺髓样癌的治疗带来了新希望。
갑상선수양암시일충소견적갑상선악성종류，유우기기원우갑상선려포방 C 세포，고여침대기타상견적갑상선종류여갑상선유두상암등적치료방법유소불동，구유자신적특점。근년래，사용락안산격매억제제적파향치료위갑상선수양암적치료대래료신희망。
Medullary thyroid cancer is a kind of rare malignancy arising from unregulated replication of parafollicular C cells of the thyroid gland. Therapeutic approaches to patients with medullary thyroid cancer have their own features,which are different from those to patients with papillary thyroid cancer,the most com-mon type of thyroid cancer. The targeted therapy using tyrosine kinase inhibitors has brought new hope for the management of aggressive medullary thyroid cancer in recent years.